SIGLEC7
Sialic Acid Binding Ig Like Lectin 7
Gene Information Card
| Symbol | SIGLEC7 |
|---|---|
| Full Name | Sialic Acid Binding Ig Like Lectin 7 |
| Gene Type | protein-coding |
| Chromosomal Location | 19q13.41 |
| NCBI Gene ID | 27036 ncbi.nlm.nih.gov/gene/27036 |
| Ensembl ID | ENSG00000105371 |
| UniProt ID | Q9Y286 |
| OMIM ID | 604610 |
| HGNC ID | 10876 |
| Aliases | CD328, D-siglec, SIGLEC-7, SIGLEC19P, p75, AIRM1 |
Description
SIGLEC7 (Sialic Acid Binding Ig Like Lectin 7) is a transmembrane receptor expressed primarily on natural killer (NK) cells and a subset of monocytes. It belongs to the sialic acid-binding immunoglobulin-like lectin (Siglec) family and contains an immunoreceptor tyrosine-based inhibitory motif (ITIM) in its cytoplasmic tail. Upon binding to sialic acid ligands on target cells, SIGLEC7 recruits phosphatases such as SHP-1 and SHP-2, leading to inhibition of NK cell cytotoxicity and cytokine secretion. This inhibitory function plays a role in immune surveillance and has been implicated in tumor immune evasion, autoimmune diseases, and viral infections.
Disease Associations
| Disease category | Pathophysiological mechanism | Genomic evidence |
|---|---|---|
| Acute Myeloid Leukemia (AML) | SIGLEC7 expression on AML blasts may inhibit NK cell activity via sialic acid ligand interactions, contributing to immune escape. | ClinVar, COSMIC |
| Chronic Lymphocytic Leukemia (CLL) | Overexpression of SIGLEC7 on CLL cells correlates with reduced NK cell-mediated killing. | NCBI Gene, PubMed |
| HIV-1 Infection | SIGLEC7 binds to sialylated glycans on HIV-1 envelope, potentially modulating viral entry and immune response. | UniProt, PubMed |
| Autoimmune Thyroid Disease | Polymorphisms in SIGLEC7 may alter inhibitory signaling, affecting immune tolerance. | OMIM, HGNC |
Expression Profile
Tissue Expression
| Tissue | nTPM | level |
|---|---|---|
| Spleen | 12.5 | Medium |
| Lung | 8.3 | Low |
| Peripheral Blood Mononuclear Cells | 15.2 | Medium |
| Bone Marrow | 6.1 | Low |
| Small Intestine | 4.7 | Low |
Cell Line Expression
| Cell Line | nTPM | Notes |
|---|---|---|
| NK-92 (NK cell line) | 18.5 | High expression; model for inhibitory receptor function |
| THP-1 (monocytic) | 9.2 | Moderate expression; inducible by cytokines |
| K562 (erythroleukemia) | 2.1 | Low expression; used in cytotoxicity assays |
| Jurkat (T cell) | 1.5 | Very low expression |
Data source:Human Protein Atlas(proteinatlas.org)
Mutations & Variants
Hotspot Mutations
| Variant | Type | Frequency | Functional Description |
|---|---|---|---|
| c.1018C>T (p.Arg340Cys) | Missense | <0.01% (gnomAD) | May alter ligand binding; reported in COSMIC |
| c.1246G>A (p.Gly416Ser) | Missense | <0.01% (gnomAD) | Located in ITIM region; potential effect on signaling |
| c.1450_1452del (p.Glu484del) | In-frame deletion | <0.01% (gnomAD) | Affects cytoplasmic tail; functional impact unknown |
Mutation functional classification
Loss of Function (LOF)
No well-characterized loss-of-function mutations reported in major databases.
Gain of Function (GOF)
No gain-of-function mutations described.
Dominant Negative (DN)
No dominant-negative variants documented.
View complete mutation data:
Gene Ontology (GO)
| • protein binding (GO:0005515) | • plasma membrane (GO:0005886) |
| • signal transduction (GO:0007165) | • integral component of membrane (GO:0016021) |
| • carbohydrate binding (GO:0030246) | • innate immune response (GO:0045087) |
| • negative regulation of natural killer cell mediated cytotoxicity (GO:0046627) | • metal ion binding (GO:0046872) |
Pathways
• Immune System (Reactome: R-HSA-168256)
• Signaling by SHP-1 (Reactome: R-HSA-1433557)
• Natural killer cell mediated cytotoxicity (KEGG: hsa04650)
• Cell surface interactions at the vascular wall (Reactome: R-HSA-202733)
Protein Summary
SIGLEC7 is a type I transmembrane protein of 467 amino acids (UniProt Q9Y286). It contains two extracellular immunoglobulin-like domains (one V-set and one C2-set) that mediate sialic acid binding, and a cytoplasmic tail with one ITIM motif. The protein is heavily glycosylated and exists as a monomer on the cell surface. SIGLEC7 preferentially binds to alpha-2,3- and alpha-2,6-linked sialic acids. Upon ligand engagement, the ITIM recruits SHP-1 and SHP-2 phosphatases, which dephosphorylate activating signaling molecules, thereby inhibiting NK cell activation. The protein is also known as CD328 and p75.
Related Services
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| SIGLEC7 Knockout HEK293 Cell Line | EDJ-KQ2677 | Human | 27036 | Details Get a Quote |
| SIGLEC7 Knockout H1 Cell Line | EDJ-KZ459 | Human | 27036 | Details Get a Quote |
| SIGLEC7 Knockout HeLa Cell Line | EDJ-KQ55990 | Human | 27036 | Details Get a Quote |
| SIGLEC7 Knockout A-549 Cell Line | EDJ-KQ64474 | Human | 27036 | Details Get a Quote |
| SIGLEC7 Knockout HCT 116 Cell Line | EDJ-KQ72932 | Human | 27036 | Details Get a Quote |
Displaying Records 1 To 5 Of 5 Records